MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
Please note: All sites must have greenlight status for protocol 21 before they can activate to protocol 23. Please contact the STAMPEDE team if you require assistance with protocol 21 activation.
Please refer to the essential documents page for all current documents.
To book protocol training dates please refer to the Upcoming Training page (password required).
If you were unable to attend the live sessions, please refer to the site staff protocol 23 training video, found on our Training Materials & Resources page with further information.
Updated Essential Documents
Note: For IBs/SPCs submitted, please go to the reference safety information page.
STAMPEDE
MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
STAMPEDE
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy
See the latest News in STAMPEDE through the link to the right.